A firm stride for regulatory by Japan’s PMDA
In Japan, the Pharmaceutical and Medical Device Agency (PMDA) is responsible from the beginning of preliminary non-clinical phases through the late phases including the pivotal clinical trials. interestingly, increasing fiscal burden and ageing society and decreasing population posing the challenges as well as emergence of unseen opportunities in Japanese pharmaceutical market. Japanese pharma economy is […]